CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Geniculate Artery Embolizationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02850068
NCT02850068N/ACompleted
CompareCT.gov

Geniculate Artery Embolization for the Treatment of Knee Pain Secondary to Osteoarthritis

University of North Carolina, Chapel Hill·interventional·Posted Jul 29, 2016·Updated Aug 20, 2019

In Brief

A clinical study evaluating Geniculate Artery Embolization for Osteoarthritis Of Knee. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

This study is to test a new treatment method, geniculate artery embolization (GAE), to reduce the severity of pain and disability caused by knee osteoarthritis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis Of Knee
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJul 29, 2016
Enrollment StartJan 25, 2017
Primary CompletionAug 3, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.9 years ago

Interventions

Geniculate Artery Embolizationdevice

Geniculate artery embolization (GAE) is a new procedure that is being used to reduce pain and disability (resulting from pain, stiffness and difficulty performing daily activities) caused by knee osteoarthritis (OA). Embolization is a procedure where physicians intentionally block the blood vessels to specific areas of the body to prevent blood flow to that region. By doing this, the decrease in blood flow will decrease the size of the area of interest. In this case, the goal is to decrease the size of inflammatory tissue around the knee, resulting in improvement of pain, stiffness and difficulty performing daily activities from OA.